Monika Joshi, Se Eun Kim, Petros Grivas, Elizabeth Wulff, Alicia K. Morgans, Kriti Mittal, Joshua Warrick, Melissa A. Reimers, Noah M. Hahn, Naomi Balzer Haas, Lynne I. Wagner, Michael A. Carducci. "A phase III randomized trial of pembrolizumab in combination with sacituzumab govitecan vs standard of care in anti–PD-(L)1–resistant advanced urothelial cancer: ECOG-ACRIN EA8231.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps4641